Literature DB >> 17573503

Gender differences in the severity of CT emphysema in COPD.

Mark T Dransfield1, George R Washko, Marilyn G Foreman, Raul San Jose Estepar, John Reilly, William C Bailey.   

Abstract

BACKGROUND: The hallmark of COPD is airflow obstruction, but this can develop on the basis of airway disease, emphysema, or both. There are gender differences in the natural history of COPD, and these may in part be explained by differences in the pathophysiology of airflow obstruction. We aimed to determine if there are gender differences in the severity of CT emphysema among COPD patients.
METHODS: Current and former smokers enrolled in the National Lung Screening Trial (NLST) at the University of Alabama at Birmingham were recruited at the time of an annual screening CT examination. We recorded demographics and smoking history, and subjects performed spirometry. Subjects were classified into modified (prebronchodilator) Global Initiative for Chronic Obstructive Lung Disease stages, and their CT scans were analyzed to determine regional and total emphysema (defined as the percentage of low attenuation areas [LAA%]; < - 950 Hounsfield units). Differences between genders were examined, and univariate and multivariate predictors of LAA% were determined.
RESULTS: A total of 396 subjects participated. Men had more regional and total CT emphysema at all stages of COPD than women (stage 0, 3.9% vs 2.4%, p = 0.001; stage I, 7.0% vs 3.7%, p = 0.015; stage II, 7.8% vs 5.5%, p = 0.063; stages III/IV, 15.8% vs 8.7%, p = 0.024). In multivariate regression analysis, only gender (p < 0.001) and FEV(1)/FVC ratio (p < 0.001) predicted total LAA%.
CONCLUSIONS: At all stages of COPD severity, men have more CT emphysema than women. This difference in radiologic expression may in part explain gender differences in the presentation and natural history of COPD. The NLST (NCT00047385) is registered at www.clinicaltrials.gov. Registered at www.clinicaltrials.gov; no.NCT00047835.

Entities:  

Mesh:

Year:  2007        PMID: 17573503     DOI: 10.1378/chest.07-0863

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  53 in total

1.  Airway wall attenuation: a biomarker of airway disease in subjects with COPD.

Authors:  George R Washko; Mark T Dransfield; Raúl San José Estépar; Alejandro Diaz; Shin Matsuoka; Tsuneo Yamashiro; Hiroto Hatabu; Edwin K Silverman; William C Bailey; John J Reilly
Journal:  J Appl Physiol (1985)       Date:  2009-04-30

2.  Levels and risks of particulate-bound PAHs in indoor air influenced by tobacco smoke: a field measurement.

Authors:  Klara Slezakova; Dionísia Castro; Cristina Delerue-Matos; Simone Morais; Maria do Carmo Pereira
Journal:  Environ Sci Pollut Res Int       Date:  2013-12-12       Impact factor: 4.223

3.  Equating quantitative emphysema measurements on different CT image reconstructions.

Authors:  Seth T Bartel; Andrew J Bierhals; Thomas K Pilgram; Cheng Hong; Kenneth B Schechtman; Susan H Conradi; David S Gierada
Journal:  Med Phys       Date:  2011-08       Impact factor: 4.071

4.  Variation in the percent of emphysema-like lung in a healthy, nonsmoking multiethnic sample. The MESA lung study.

Authors:  Eric A Hoffman; Firas S Ahmed; Heather Baumhauer; Mathew Budoff; J Jeffrey Carr; Richard Kronmal; S Reddy; R Graham Barr
Journal:  Ann Am Thorac Soc       Date:  2014-07

5.  Why do we need a nonhuman primate model of smoking-induced COPD?

Authors:  Jeffrey L Curtis; Christine M Freeman
Journal:  Am J Pathol       Date:  2015-01-07       Impact factor: 4.307

6.  Sex differences in function and structure of the quadriceps muscle in chronic obstructive pulmonary disease patients.

Authors:  Pilar Ausín; Juana Martínez-Llorens; Marina Sabaté-Bresco; Carme Casadevall; Esther Barreiro; Joaquim Gea
Journal:  Chron Respir Dis       Date:  2016-12-06       Impact factor: 2.444

7.  Gender differences in COPD: are women more susceptible to smoking effects than men?

Authors:  Inga-Cecilie Sørheim; Ane Johannessen; Amund Gulsvik; Per S Bakke; Edwin K Silverman; Dawn L DeMeo
Journal:  Thorax       Date:  2010-06       Impact factor: 9.139

8.  Effects of CT section thickness and reconstruction kernel on emphysema quantification relationship to the magnitude of the CT emphysema index.

Authors:  David S Gierada; Andrew J Bierhals; Cliff K Choong; Seth T Bartel; Jon H Ritter; Nitin A Das; Cheng Hong; Thomas K Pilgram; Kyongtae T Bae; Bruce R Whiting; Jason C Woods; James C Hogg; Barbara A Lutey; Richard J Battafarano; Joel D Cooper; Bryan F Meyers; G Alexander Patterson
Journal:  Acad Radiol       Date:  2010-02       Impact factor: 3.173

9.  Quantitative airway assessment on computed tomography in patients with alpha1-antitrypsin deficiency.

Authors:  Tsuneo Yamashiro; Shin Matsuoka; Raúl San José Estépar; Alejandro Diaz; John D Newell; Robert A Sandhaus; Patricia J Mergo; Mark L Brantly; Sadayuki Murayama; John J Reilly; Hiroto Hatabu; Edwin K Silverman; George R Washko
Journal:  COPD       Date:  2009-12       Impact factor: 2.409

10.  Prevalence and correlates of pulmonary emphysema in smokers and former smokers. A densitometric study of participants in the ITALUNG trial.

Authors:  Gianna Camiciottoli; Edoardo Cavigli; Luca Grassi; Stefano Diciotti; Ilaria Orlandi; Marco Zappa; Giulia Picozzi; Andrea Lopes Pegna; Eugenio Paci; Fabio Falaschi; Mario Mascalchi
Journal:  Eur Radiol       Date:  2008-08-09       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.